Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
Reuters2026/08/29 04:28- Cambria posted a net loss of CAD 78.33 million for the six months ended June 30, 2026; loss per share narrowed to CAD 0.23.
- Second-quarter net loss narrowed to CAD 2.96 million; per-share loss tightened to CAD 0.01.
- Cash and cash equivalents climbed 83.18% to CAD 142.77 million; working capital totaled CAD 98.82 million.
- Financing cash inflows rose to CAD 112.26 million, driven by CAD 131.85 million of share issuance proceeds during the half-year.
- Management expects available funds to cover development at Premier and Red Mountain, mine-site activities, and corporate needs for 12 months.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hyperliquid’s $249B volume lead – Can HYPE survive the crowd it created?

TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
